Obesity and weight management challenges have affected millions of people worldwide. Few topics in healthcare have attracted as much public attention and debate as GLP-1 weight-loss medications. Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound have become central to global conversations across medical communities, social media platforms, and mainstream news. Amid this growing interest, weight-loss coach and metabolic health advocate Sharon Polsky is aiming to bring greater clarity and balance to the discussion. Through her new book, Weight Loss Decoded: Unlocking the Truth About GLP Weight Loss Medications, Polsky presents an evidence-informed, accessible perspective on one of the most significant developments in modern metabolic medicine.
With more than 25 years of experience in medical weight loss and metabolic health, Sharon Polsky has worked alongside functional medicine specialists at a dedicated metabolic health clinic. They have helped more than 5, 000 patients through GLP-based treatments. She has noted that many patients successfully achieved their weight-loss goals and maintained long-term results through structured coaching, medical supervision, and ongoing lifestyle support. Working with thousands of patients has provided Polsky with extensive, firsthand insight into how individuals respond to GLP-1-based treatments, including their successes and difficulties. These experiences inspired her to write Weight Loss Decoded, a book aimed at providing clear, evidence-based information in an environment increasingly influenced by misinformation about obesity.
“I started seeing a lot of misinformation on the internet,” Polsky explained during a recent interview. “The book is really not designed to convince you to do GLP weight-loss medications. It is designed to inform you and let you make a decision based on where you are in your weight-loss journey.”
According to Polsky, the public conversation surrounding GLP-1 therapies lacks important context. She believes people are not aware that peptide-based treatments have been utilized in functional medicine for years and that the medications work by supporting biological processes.
“People keep talking about these medications as if they’re new,” she said. “They’re not new medications. We’ve used them in functional medicine for more than 15 years.”
In her book Weight Loss Decoded, Polsky explains that GLP-1 is a naturally present hormone in the body for controlling appetite, blood sugar, insulin production, and digestion. Medications such as Ozempic and Wegovy contain semaglutide, while Mounjaro and Zepbound contain tirzepatide, which are substances that affect the body’s metabolic processes related to weight control. The book covers the scientific aspects of the treatments, educating readers about how the drugs work and how individuals derive advantages from them.

She discussed the side effects of GLP-1 medications, such as nausea, gastrointestinal discomfort, or mild injection-site reactions. It may cause more complications when people are prescribed medication without a structured lifestyle. The drug’s outcome depends on education and behavioral support. She also mentions the misconceptions about obesity itself in her book. She argues that obesity should not be viewed as a simple matter of willpower. Instead, she educates it as a complex metabolic condition influenced by genetics, hormones, environment, and lifestyle factors.
The GLP-1 medications do not work the same for everyone. Some patients may use these medications for several months to reach their weight-loss goals. Some individuals with conditions such as insulin resistance, PCOS, or long-term obesity may need more attention to their ongoing health challenges. She emphasized that good results come from a proper treatment plan, which is designed according to the patient’s medical history.
During the interview, she addressed another major issue, which is that people get easily affected by social media on health education. Instead of relying on online trends, she encourages the audience to seek information from credible sources, such as research, asking questions, and developing a deeper understanding of metabolic health before making treatment decisions.
“Polsky also believes the future of obesity treatment is undergoing a significant transformation. When asked to describe the future of metabolic medicine in a single word, her answer was immediate: “Revolutionary.”
Polsky is not only talking about medical treatments but also strongly focuses on healthy lifestyle habits as well. She identifies sleep, stress management, water, food, and exercise as the significant elements that help in both weight control and well-being. She motivates readers to focus on these fundamental things and highlights that the basis for long-term achievement is regular daily habits instead of quick fixes.
“Her message to readers is very simple and hopeful: ‘It’s never too late. It’s never too late to start walking. It’s never too late to start eating healthier. Even if you don’t lose weight, you will feel better.”
Ultimately, Weight Loss Decoded is not promoting a particular medication. Instead, it is about understanding, providing health education, and showing compassion. Drawing on decades of experience and helping thousands of patients, Polsky offers readers a thoughtful perspective on modern obesity care while encouraging them to make informed decisions based on evidence rather than stigma.
Explore the Official Website:
Website: https://www.sharonpolsky.com/
Follow Sharon Polsky on Social Media:
Facebook Link: https://www.facebook.com/spolskyGLP1expert
Instagram Link: https://www.instagram.com/sharonpolsky/
LinkedIn Link: https://www.linkedin.com/in/sharon-polsky-5b990b41
YouTube Link: https://www.youtube.com/@GLP1_Expert
TikTok Link: https://www.tiktok.com/@glp1_expert
